Kimberly-Clark (NYSE:KMB – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Wednesday.
A number of other research firms have also issued reports on KMB. Citigroup reduced their target price on shares of Kimberly-Clark from $125.00 to $118.00 and set a “sell” rating on the stock in a report on Wednesday, January 15th. Piper Sandler reiterated an “overweight” rating and issued a $158.00 price objective (down from $161.00) on shares of Kimberly-Clark in a research note on Wednesday. UBS Group boosted their target price on Kimberly-Clark from $132.00 to $134.00 and gave the stock a “neutral” rating in a research note on Wednesday. Barclays reduced their price target on Kimberly-Clark from $144.00 to $132.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on Kimberly-Clark from $146.00 to $147.00 and gave the stock a “hold” rating in a research report on Tuesday, October 8th. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, Kimberly-Clark currently has a consensus rating of “Hold” and an average target price of $143.64.
View Our Latest Research Report on Kimberly-Clark
Kimberly-Clark Trading Up 0.9 %
Kimberly-Clark (NYSE:KMB – Get Free Report) last released its earnings results on Tuesday, January 28th. The company reported $1.50 earnings per share for the quarter, meeting the consensus estimate of $1.50. Kimberly-Clark had a return on equity of 198.59% and a net margin of 12.97%. On average, equities analysts expect that Kimberly-Clark will post 7.32 earnings per share for the current year.
Insiders Place Their Bets
In other news, VP Andrew Drexler sold 3,000 shares of the stock in a transaction that occurred on Friday, November 22nd. The stock was sold at an average price of $139.01, for a total value of $417,030.00. Following the completion of the sale, the vice president now directly owns 5,053 shares of the company’s stock, valued at approximately $702,417.53. This represents a 37.25 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.62% of the company’s stock.
Institutional Trading of Kimberly-Clark
Institutional investors and hedge funds have recently bought and sold shares of the business. Park Avenue Securities LLC raised its holdings in shares of Kimberly-Clark by 77.4% in the fourth quarter. Park Avenue Securities LLC now owns 13,786 shares of the company’s stock valued at $1,807,000 after buying an additional 6,016 shares during the last quarter. Pensionfund Sabic increased its position in Kimberly-Clark by 45.5% in the 4th quarter. Pensionfund Sabic now owns 12,800 shares of the company’s stock valued at $1,677,000 after acquiring an additional 4,000 shares during the period. Barclays PLC raised its stake in Kimberly-Clark by 19.4% during the 3rd quarter. Barclays PLC now owns 1,681,671 shares of the company’s stock valued at $239,267,000 after acquiring an additional 273,813 shares during the last quarter. Vest Financial LLC lifted its position in Kimberly-Clark by 6.5% during the 3rd quarter. Vest Financial LLC now owns 347,269 shares of the company’s stock worth $49,409,000 after acquiring an additional 21,339 shares during the period. Finally, Aprio Wealth Management LLC grew its stake in shares of Kimberly-Clark by 20.0% in the 4th quarter. Aprio Wealth Management LLC now owns 2,792 shares of the company’s stock valued at $366,000 after purchasing an additional 466 shares during the last quarter. Hedge funds and other institutional investors own 76.29% of the company’s stock.
About Kimberly-Clark
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
Featured Stories
- Five stocks we like better than Kimberly-Clark
- EV Stocks and How to Profit from Them
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- What is an Earnings Surprise?
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.